Exhibitor Product Theater - The ENTYVIO (vedolizumab) You Know With An Exciting Update

Miguel D. Regueiro, MD, FACG

This program is sponsored by Takeda Pharmaceuticals U.S.A., Inc.

An interactive presentation of the latest clinical data, dosing and administration guidance, and patient access information. Hear the ENTYVIO highlights in under 30 minutes.

Open to all in-person ACG 2023 attendees, industry-sponsored product theater events provide additional educational opportunities. These programs are independent of the ACG 2023 Annual Scientific Meeting and Postgraduate Course programs. No CME is provided for Exhibitor Product Theater presentations.